skip to primary navigationskip to content

11.09.15 Jonathon Pines to head up Division of Cancer Biology at ICR

last modified Sep 13, 2015 10:41 AM
Jonathon Pines moves to new role as Head of Division of Cancer Biology at the Institute of Cancer Research, London, on 1st October 2015.
11.09.15 Jonathon Pines to head up Division of Cancer Biology at ICR

Dr Jonathon Pines

Dr Jonathon Pines, Senior Group Leader and Cancer Research UK Senior Research Fellow at the Gurdon Institute, is to take up a new post at the Institute of Cancer Research (ICR) in London from 1st October 2015. After 23 years at the Gurdon Institute, Jon is embarking on a new stage in his career, becoming Head of ICR’s Division of Cancer Biology.

Jon’s work at the Gurdon Institute has led to several key discoveries on the regulation and process of cell division, furthering our understanding of what goes wrong in cancer as cells break free from their normal controls.  As the ICR’s new Professor of Cell Division, Jon plans to build on this line of research to look at how chromosome segregation goes wrong in cancer cells and devise ways to target this with new anti-mitotic drugs.

"I’ve had a very happy, productive and inspiring time at the Gurdon Institute," says Jon, "and I take with me many ideas for how to create a supportive and collaborative environment for research, especially for how to nurture those early in their career.  I have also found a huge benefit from experiencing the diversity of research directions represented at the Gurdon Institute, notably the fascinating processes of developmental biology that continue to provide striking insights into the development of cancer, as originally envisaged by our founders John Gurdon and Ron Laskey.
Now it is time for me to channel this experience into a new environment with a focus on developing anti-cancer therapies. I am very lucky to be taking several of my research team with me to London and am looking forward to new challenges and new collaborations at the ICR. I will, however, greatly miss the daily interactions with the fantastic support staff who make the Gurdon Institute such an easy place to do research, and my exceptional colleagues who make research fun to do." 

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48

The developmental origin of brain tumours: a cellular and molecular framework

Bioinformatics challenges and perspectives when studying the effect of epigenetic modifications on alternative splicing

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity

Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer

Predominant Asymmetrical Stem Cell Fate Outcome Limits the Rate of Niche Succession in Human Colonic Crypts

G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst

Validating the concept of mutational signatures with isogenic cell models

A PAX5-OCT4-PRDM1 developmental switch specifies human primordial germ cells

Targeting NAT10 enhances healthspan and lifespan in a mouse model of human accelerated aging syndrome

An alternative mode of epithelial polarity in the Drosophila midgut

Detection of functional protein domains by unbiased genome-wide forward genetic screening

Fank1 and Jazf1 promote multiciliated cell differentiation in the mouse airway epithelium

Genome organization at different scales: nature, formation and function

Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations


Link to full list on PubMed